Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/28/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/22/16 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/22/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/21/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/20/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/16/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/15/16 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/15/16 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
65 | |
| 12/14/16 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 12/12/16 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
89 |
